60 Degrees Pharmaceuticals WarrantSXTPW
About: 60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
Employees: 3
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
8.21% less ownership
Funds ownership: 33.96% [Q4 2024] → 25.74% (-8.21%) [Q1 2025]
14% less funds holding
Funds holding: 7 [Q4 2024] → 6 (-1) [Q1 2025]
42% less capital invested
Capital invested by funds: $19.1K [Q4 2024] → $11K (-$8.04K) [Q1 2025]
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Research analyst outlook
We haven’t received any recent analyst ratings for SXTPW.
Financial journalist opinion
We haven’t received any recent news articles for SXTPW.